Remove Blood Pressure Remove Diabetes Remove Hypertension
article thumbnail

New Study to Examine Hypercortisolism in Resistant Hypertension

DAIC

will establish the prevalence of endogenous hypercortisolism in patients with resistant hypertension. Resistant hypertension is defined by the American Heart Association as elevated blood pressure despite the use of three or more antihypertensive medications in different classes, including a diuretic.

article thumbnail

Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study

Frontiers in Cardiovascular Medicine

Objectives To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort. This analysis shows the baseline clinical characteristics of patients with hypertension.

article thumbnail

One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

DAIC

Akshay Desai, MD “Compared to placebo, a single injection of zilebesiran resulted in clinically meaningful reductions in blood pressure at three months when added to commonly used antihypertensive treatments,” said Akshay Desai, MD, MPH , a cardiologist at Brigham and Women’s Hospital in Boston and a study coauthor. “In

article thumbnail

Gastric Bypass Surgery’s Durable Hypertension Impact

CardiacWire

The associations between obesity and hypertension are widely known, but a new JACC study reveals that weight-reducing gastric bypass surgery has a significant and lasting impact on patients’ need for antihypertensives. vs. 2.4%) All gastric bypass patients eliminated their resistant hypertension (from 15.2%

article thumbnail

Blood Pressure Control Target in Diabetes

American College of Cardiology

The goal of the BPROAD trial was to determine the efficacy and safety of an intensive blood pressure (BP)-lowering strategy in patients with type 2 diabetes mellitus (T2DM) and hypertension with respect to future cardiovascular disease (CVD) events.

article thumbnail

BPROAD — End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes?

The New England Journal of Medicine

Elevated blood pressure mediates much of the organ toxicity affecting persons with type 2 diabetes. The management of hypertension occupies as much clinical attention as that of dysglycemia, yet the recommended blood-pressure target in type 2 diabetes remains controversial.

article thumbnail

Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study

Cardiovascular Diabetology

We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.